Surge in Surprise Billing Disputes: IDR Process Faces challenges and Rising Costs
The federal Self-reliant Dispute Resolution (IDR) process, established by the No Surprises Act to protect patients from unexpected out-of-network medical bills, is experiencing a important increase in utilization. Recent data from the Centers for Medicare & Medicaid Services (CMS) reveals that nearly 1.2 million cases were submitted in the first half of 2025 – a nearly 40% jump from the latter half of 2024.While dispute resolution is accelerating,with over 1.3 million disputes processed, the system continues to grapple with inefficiencies and concerns about potential exploitation.
The No Surprises Act and the IDR Process
Enacted to shield consumers from the financial burden of surprise medical bills, the No Surprises Act created a framework for resolving payment disputes between healthcare providers and insurance companies when patients receive out-of-network care. The IDR process is central to this framework. It allows both the provider and insurer to submit their proposed payment rates for a service, and a neutral third-party arbiter selects one of the offers.
Despite it’s initial promise, the IDR process has faced hurdles since its launch in April 2022, including legal challenges and ongoing disagreements between payers and providers. Both sides contend the process is biased in favor of the other.
Rising Volume and Persistent Inefficiencies
The surge in disputes submitted to the IDR portal highlights the ongoing need for a fair and efficient resolution mechanism. Arbiters are working to reduce the existing backlog, increasing processing rates by almost 50% in the first half of 2025 compared to the previous six months. However, a significant portion of submitted disputes – around 20% – are deemed ineligible for IDR, contributing to delays and administrative burdens. The CMS acknowledges that improving eligibility reviews is crucial to streamlining the process.
Concerns Over Exploitation and Cost Inflation
A key concern revolves around the concentration of disputes originating from a small number of provider groups, many of wich are backed by private equity firms. the top 10 initiating parties accounted for nearly 70% of all disputes in the first half of 2025, with the top three – HaloMD, Team Health, and SCP Health – representing approximately 44%.
This concentration raises questions about whether the IDR process is being leveraged as a buisness strategy to inflate reimbursement rates.data indicates that providers win a substantial majority of disputes – 88% – and frequently enough receive payment amounts three to four times higher than comparable in-network rates.
Payer groups argue that some providers are submitting bills that shouldn’t qualify for IDR, further exacerbating the problem. Conversely, providers maintain that insurers are intentionally submitting artificially low payment offers.
Financial impact and Future Outlook
The inefficiencies and potential for exploitation within the IDR process are contributing to increased healthcare costs. Research suggests that the IDR process has already resulted in an estimated $5 billion in additional costs to the U.S. healthcare system in its first three years.
Regulators are working to address these issues and are expected to release a final rule aimed at clarifying IDR operations, improving eligibility determinations, and accelerating payment decisions. However, until these improvements are implemented, the IDR process will likely continue to be a source of contention and a driver of rising healthcare expenditures.
keywords:
* Primary Topic: Surprise Billing Dispute resolution
* Primary Keyword: No Surprises Act IDR
* Secondary Keywords: surprise medical bills, independent dispute resolution, healthcare costs, out-of-network care, CMS, medical billing disputes, healthcare arbitration, no Surprises Act, private equity healthcare, healthcare reimbursement.
Worth a look